$KNTK

ISQ Global Fund II GP LLC sold $16.0M of KNTK (indirect holdings)

ISQ Global Fund II GP LLC sold 310,691 indirectly-held shares of Kinetik Holdings Inc. (KNTK) at an average of $51.60 ($50.59–$52.36, $16.03M total) across 5 trades over 2026-08-10 to 2026-08-12.

Original reporting
SEC EDGAR · ISQ Global Fund II GP LLC
Published Aug 12, 2026, 11:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 11:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$KNTK
Neutral
medium confidence
Mentioned
$KNTK
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KNTKNeutralLow
01

Why it matters

The newest disclosed fact is the $16.0M open-market sale across five trades at $50.5874 to $52.3589 per share, with remaining holdings of 1,354,129 shares.

02

Market read

This is a primary-source ownership transaction update that may influence short-term sentiment but lacks fundamental catalysts.

03

What to watch

Indirect ownership and fund-level rebalancing can make the signal weaker than a direct insider sale; traders should check for follow-on filings and overall volume/float context.

Relevance 7/10Novelty 6/10Timing: filed 2026-08-12 after trades from 2026-08-10 to 2026-08-12

Background

The article is an SEC Form 4 insider transaction disclosure for Kinetik Holdings Inc., reported by ISQ Global Fund II GP LLC as a 10% owner via indirect holdings.

Company-level read

Ticker impact

$KNTKNeutralMedium confidence
Context

ISQ Global Fund II GP LLC, a 10% owner, sold $16.0M of Kinetik Holdings shares in open-market trades dated 2026-08-10 to 2026-08-12.

Expected impact

Near-term: limited, mostly sentiment-driven. Medium-term: depends on whether further insider selling continues.

Evidence & confidence

The filing is a primary Form 4 disclosure with transaction size and dates, but it provides no new operating, guidance, or regulatory information.

Market effects

No direct sector read-through; this is an issuer-specific ownership transaction.

None indicated.

None indicated.

Counterpoint

The sale may be routine liquidity management by an owner fund, especially since it is not tied to a pre-arranged 10b5-1 plan in the filing.

Key entities

  • Kinetik Holdings Inc.

    Subject of the Form 4 insider transaction disclosure (KNTK).

  • ISQ Global Fund II GP LLC

    Reporter of the indirect open-market sale totaling about $16.0M across 2026-08-10 to 2026-08-12.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KNTKMedAI 8/10

Why is Kinetik Holdings stock surging today?

Kinetik Holdings' stock rose 5.2% in after-hours trading after Bloomberg reported the company is exploring strategic alternatives, including a potential sale. The company posted record Q2 2026 results with revenue up 36% YoY and net income more than doubled. Kinetik's management had raised its full-year 2026 guidance. U.S. equities broadly sold off during regular trading hours, with the S&P 500, Dow Jones, and Nasdaq all declining.

Med

Kinetik stock jumps 5% on potential sale exploration report

Kinetik Holdings Inc. (KNT) shares rose 5% in after-hours trading after reports it is exploring strategic options, including a potential sale. The company, backed by Blackstone Inc. (BX), has a market value of $8.9B. No final decision has been made. Kinetik closed regular trading at $54.55, down 0.8% but up 30% over the past year.

$KNTKMed

Kinetik Q2 Earnings Call Highlights

Kinetik (NYSE:KNTK) Q2 earnings call said Waha pricing normalization and faster curtailment return, higher WTI and liquids assumptions, and system operating improvements supported a revised outlook. It raised 2026 capex to about $560M, expects Q3 Adjusted EBITDA $260M-$270M and Q4 $270M-$280M, and lifted 2026 volume growth to mid- to high-single digits.